Info@ThinkPinkRocks.com

The New York Times Commends Memorial Sloan-Kettering’s Stance on a Costly Cancer Drug

1 comment By Julie Grisham, MS, Science Writer/Editor   |  Friday, November 16, 2012 Memorial Sloan-Kettering has been praised for taking a stand on the price for a new cancer drug that costs more than twice as much as another, similar drug. read more

Link:
The New York Times Commends Memorial Sloan-Kettering’s Stance on a Costly Cancer Drug

Share

Leave a Reply

Solve : *
10 + 22 =